Education
About Us
Working with TipRanks
Follow Us
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
RESEARCH TOOLSreports
ELTP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $0.75
Previous CloseN/A
Volume475.03K
Average Volume (3M)1.09M
Market Cap
$747.79M
Enterprise Value$718.63M
Total Cash (Recent Filing)$8.29M
Total Debt (Recent Filing)$11.18M
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Jul 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,068,273,100
10 Day Avg. Volume1,706,022
30 Day Avg. Volume1,090,705
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)19.64
Price to Sales (P/S)0.00
P/FCF Ratio209.10
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue2.72
Enterprise Value/Gross Profit23.54
Enterprise Value/Ebitda286.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Elite Pharmaceuticals News
PremiumCompany Announcements
Elite Pharmaceuticals Launches Generic Percocet Version
PremiumCompany Announcements
Elite Pharmaceuticals Expands with New Northvale Facility
PremiumCompany Announcements
Elite Pharmaceuticals Reports Decline in Q3 2025 Earnings
PremiumCompany Announcements
Elite Pharmaceuticals Reports Q3 2025 Revenue DeclinePremiumCompany Announcements
Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Market
PremiumCompany Announcements
Elite Pharmaceuticals Launches Generic Version of Norco
PremiumCompany Announcements
Elite Pharmaceuticals Gains FDA Approval for Generic Vyvanse
PremiumCompany Announcements
Elite Pharmaceuticals Reports Robust Q2 Financial GrowthOptions Prices
Currently, No data available
---
Ownership Overview
20.74% Insiders
0.01% Other Institutional Investors
99.99% Public Companies and Individual Investors
ELTP FAQ
What was Elite Pharmaceuticals’s price range in the past 12 months?
Elite Pharmaceuticals lowest stock price was $0.16 and its highest was $0.75 in the past 12 months.
What is Elite Pharmaceuticals’s market cap?
Elite Pharmaceuticals’s market cap is $747.79M.
When is Elite Pharmaceuticals’s upcoming earnings report date?
Elite Pharmaceuticals’s upcoming earnings report date is Jul 07, 2025 which is in 24 days.
How were Elite Pharmaceuticals’s earnings last quarter?
Elite Pharmaceuticals released its earnings results on Feb 13, 2025. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Elite Pharmaceuticals overvalued?
According to Wall Street analysts Elite Pharmaceuticals’s price is currently Overvalued.
Does Elite Pharmaceuticals pay dividends?
Elite Pharmaceuticals does not currently pay dividends.
What is Elite Pharmaceuticals’s EPS estimate?
Elite Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elite Pharmaceuticals have?
Elite Pharmaceuticals has 1,068,273,100 shares outstanding.
What happened to Elite Pharmaceuticals’s price movement after its last earnings report?
Elite Pharmaceuticals reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.636%.
Which hedge fund is a major shareholder of Elite Pharmaceuticals?
Among the largest hedge funds holding Elite Pharmaceuticals’s share is Fisher Asset Management LLC. It holds Elite Pharmaceuticals’s shares valued at 0.
Elite Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ELTP Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 82.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $562.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 4.8%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
304.16%
12-Months-Change
Fundamentals
Return on Equity
-43.41%
Trailing 12-Months
Asset Growth
21.50%
Trailing 12-Months
Company Description
Elite Pharmaceuticals
Elite Pharmaceuticals, Inc. (ELTP) is a specialty pharmaceutical company engaged in the development and manufacturing of oral, controlled-release products, and generic pharmaceuticals. The company operates in the healthcare and pharmaceutical sectors, focusing on niche drug delivery systems for the treatment of pain and other conditions. Elite Pharmaceuticals leverages its proprietary technology to create and market a diverse portfolio of products, primarily targeting the generic drug market.
ELTP Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call demonstrated strong revenue and profit growth, supported by a robust pipeline and strategic facility expansion, though some supply chain challenges and financial liabilities were noted.Read More>Technical Analysis
Oruka Therapeutics
―
Precigen
―
Relay Therapeutics
―
Opthea Limited Sponsored ADR
―
Mind Medicine
―